US Q3 2026 Earnings: Tenable, Biogen, and Regional Banks Deliver Broad Beats

The Quick Take

• Tenable Holdings beat Q3 guidance with $276.4M revenue and 59% record Tenable One new business adoption
• Biogen revenue climbed 11% on LEQEMBI and SPINRAZA strength, lifting 2026 EPS guidance to $12.20-$13.00
• NBT Bancorp posted record net interest income of $143M with a 3.78% NIM amid elevated commercial payoffs
• Bladex recorded a record $15 billion Latin American commercial portfolio and $79.8M net interest income
• Franklin Electric posted record Q3 adjusted EPS of $1.50 and raised full-year guidance despite margin headwinds

The US Q3 2026 earnings season shows broad-based resilience across technology, pharmaceuticals, and financial services. Tenable Holdings beat quarterly guidance with $276.4 million in revenue and posted record Tenable One platform adoption at 59% of new business, signaling accelerating enterprise cybersecurity consolidation. Biogen's 11% revenue growth, fueled by LEQEMBI and SPINRAZA commercialization momentum, enabled a guidance raise. Regional banks including NBT Bancorp and Northwest Bancshares both reported record net interest income, suggesting the rate environment continues to support banking sector profitability through Q4.

Tenable's record Tenable One adoption creates a positive read-through for cybersecurity platform peers CrowdStrike and Palo Alto Networks, as enterprise customers increasingly consolidate onto single-vendor solutions. Biogen's LEQEMBI trajectory reinforces the Alzheimer's treatment market thesis, positive for Eisai and Roche's neurology pipelines. Bladex's record $15 billion Latin American portfolio highlights sustained cross-border trade finance demand, constructive for EM-focused peers. Franklin Electric's guidance raise — despite international water softness — confirms US water infrastructure capex remains durable through year-end 2026.

Forward-looking, watch Tenable's full-year ARR guidance update and Biogen's Q4 LEQEMBI script growth data for signs that the guidance raise is sustainable. For regional banks, NBT flagged elevated commercial payoffs as the key risk to Q4 NIM — track whether this reflects temporary refinancing or permanent balance sheet repositioning. The macro determinant across all these sectors is the Fed's December rate decision: a hold supports banking NIM, while a cut could accelerate the biotech capital formation cycle and technology spending. Monitor Spok's software backlog trajectory as an early indicator of enterprise communication platform demand.

Synthesized from 8 sources.